CB Richard Ellis's The Pharamaceutical Sector: Real Estate Implications of Industry-Wide Change

"CBRE’s survey of key industry decision makers demonstrates that the top ten global pharmaceutical (pharma) companies occupy at least 430m sq ft of office, manufacturing and specialist research space around the world, of which approximately 75% is owned - one of the highest ownership ratios of any corporate sector."

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.

Registered users and subscribers SIGN IN here to continue